The role of concomitant chemoradiotherapy in the treatment of non‑small cell lung cancer

01/2021

MUDr. Jaromír Roubec, Ph.D.; MUDr. Jaromír Richter

Komplexní onkologické centrum, Nemocnice Nový Jičín

SUMMARY

In the overview the authors discuss the actual approaches in the concomitant chemoradiotherapy based on the previous results and meta-analysis and discuss the new possibilities in the combined chemoradiotherapy and immunotherapy of the locoregional advanced non-small cell lung cancer.

Key words

NSCLC, concomitant chemoradiotherapy, checkpoint inhibitors